Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 5670 [2020-01809]
Download as PDF
<![CDATA[
5670
Federal Register / Vol. 85, No. 21 / Friday, January 31, 2020 / Notices
approach if it satisfies the requirements
of the applicable statutes and
regulations.
II. Paperwork Reduction Act of 1995
This draft guidance refers to
previously approved collections of
information found in FDA regulations.
These collections of information are
subject to review by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995
(44 U.S.C. 3501–3521). The collections
of information in 21 CFR 601.12 and
Form FDA 356h have been approved
under OMB control number 0910–0338;
the collections of information in 21 CFR
parts 610 and 630 have been approved
under OMB control numbers 0910–
0116.
III. Electronic Access
Persons with access to the internet
may obtain the draft guidance at either
https://www.fda.gov/vaccines-bloodbiologics/guidance-complianceregulatory-information-biologics/
biologics-guidances or https://
www.regulations.gov.
Dated: January 27, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–01815 Filed 1–30–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Centers for
Disease Control and Prevention (CDC)/
HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and
Treatment (CHAC) has scheduled a
public meeting. Information about
CHAC can be found at https://
www.cdc.gov/maso/facm/facm
CHACHSPT.html.
DATES: March 5, 2020, 3:00 p.m.—4:00
p.m. Eastern Time (ET).
ADDRESSES: This meeting will be held
by webinar and will accommodate up to
100 attendees. To access the virtual
meeting, please use the information
below.
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:16 Jan 30, 2020
Jkt 250001
• Webinar link: https://
hrsa.connectsolutions.com/chac_
business_meeting/
• Conference call-in number:
Æ Call in: 888–790–1964.
Æ Passcode: 1251991.
and phone number listed above at least
10 business days prior to the meeting.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2020–01809 Filed 1–30–20; 8:45 am]
BILLING CODE 4165–15–P
FOR FURTHER INFORMATION CONTACT:
Theresa Jumento, Public Health
Advisor, HIV/AIDS Bureau, HRSA, 5600
Fishers Lane, Rockville, Maryland
20857; 301–443–5807; or
CHACAdvisoryComm@hrsa.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
CHAC was
established under Section 222 of the
Public Health Service (PHS) Act, [42
U.S.C. Section 217a], as amended.
The purpose of CHAC is to advise the
Secretary of HHS, the Director of CDC,
and the HRSA Administrator regarding
objectives, strategies, policies, and
priorities for HIV, viral hepatitis, and
other STDs; prevention and treatment
efforts including surveillance of HIV
infection, viral hepatitis, other STDs,
and related behaviors; epidemiologic,
behavioral, health services, and
laboratory research on HIV, viral
hepatitis, and other STDs; identification
of policy issues related to HIV/viral
hepatitis/STD professional eduction,
patient healthcare delivery, and
prevention services; agency policies
about prevention of HIV, viral hepatitis
and other STDs; treatment, healthcare
delivery, and research and training;
strategic issues influencing the ability of
CDC and HRSA to fulfill their missions
of providing prevention and treatment
services; programmatic efforts to
prevent and treat HIV, viral hepatitis,
and other STDs; and support to the
agencies in their developoment of
responses to emerging health needs
related to HIV, viral hepatitis, and other
STDs.
During the March 5, 2020, meeting,
CHAC will discuss issues related to a
CDC pilot on recency assay-based
incidence estimation and the President’s
initiative on ‘‘Ending the HIV Epidemic:
A Plan for America.’’ Agenda items are
subject to change as priorities dictate.
Due to the nature and time limitations
of the meeting, members of the public
will not have an opportunity to provide
oral comments, although written
comments may be submitted prior to the
meeting, or up to 5 business days after
the meeting, to Theresa Jumento at the
contact information listed above.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Theresa Jumento at the address
National Advisory Committee on Rural
Health and Human Services
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Health Resources and Services
Administration
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Secretary’s
National Advisory Committee on Rural
Health and Human Services
(NACRHHS) has scheduled a public
meeting. Information about NACRHHS
and the agenda for this meeting can be
found on the NACRHHS website at
https://www.hrsa.gov/advisorycommittees/rural-health/.
DATES: March 2, 2020, 8:30 a.m.–5:15
p.m. Eastern Time (ET); March 3, 2020,
8:30 a.m.–5:15 p.m. ET; and March 4,
2020, 8:30 a.m.–11:15 a.m. ET.
ADDRESSES: The address for the meeting
is the Center for Disease Control and
Prevention (CDC) Global
Communications Center (GCC)
Auditorium B3, 1600 Clifton Road,
Atlanta, GA 30329.
On the morning of March 3, 2020,
NACRHHS will break into
subcommittees. One subcommittee will
travel to Mercer School of Medicine,
1550 College St., Macon, GA 31207. The
other subcommittee will travel to Health
Services Center, 608 Martin Luther King
Drive, Hobson City, AL 36201. In the
afternoon, at approximately 4:00 p.m.
ET., NACRHHS will reconvene at the
CDC GCC.
FOR FURTHER INFORMATION CONTACT:
Steven Hirsch, Administrative
Coordinator at the Federal Office of
Rural Health Policy, HRSA, 5600
Fishers Lane, 17W59D, Rockville,
Maryland 20857; 301–443–7322; or
shirsch@hrsa.gov.
SUPPLEMENTARY INFORMATION:
NACRHHS provides advice and
recommendations to the Secretary of
HHS (Secretary) on policy, program
development, and other matters of
significance concerning both rural
health and rural human services.
SUMMARY:
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 85, Number 21 (Friday, January 31, 2020)]
[Notices]
[Page 5670]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01809]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Centers for Disease Control and Prevention
(CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment (CHAC) has scheduled a public meeting.
Information about CHAC can be found at https://www.cdc.gov/maso/facm/facmCHACHSPT.html.
DATES: March 5, 2020, 3:00 p.m.--4:00 p.m. Eastern Time (ET).
ADDRESSES: This meeting will be held by webinar and will accommodate up
to 100 attendees. To access the virtual meeting, please use the
information below.
Webinar link: https://hrsa.connectsolutions.com/chac_business_meeting/
Conference call-in number:
[cir] Call in: 888-790-1964.
[cir] Passcode: 1251991.
FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Public Health
Advisor, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland
20857; 301-443-5807; or [email protected].
SUPPLEMENTARY INFORMATION: CHAC was established under Section 222 of
the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], as
amended.
The purpose of CHAC is to advise the Secretary of HHS, the Director
of CDC, and the HRSA Administrator regarding objectives, strategies,
policies, and priorities for HIV, viral hepatitis, and other STDs;
prevention and treatment efforts including surveillance of HIV
infection, viral hepatitis, other STDs, and related behaviors;
epidemiologic, behavioral, health services, and laboratory research on
HIV, viral hepatitis, and other STDs; identification of policy issues
related to HIV/viral hepatitis/STD professional eduction, patient
healthcare delivery, and prevention services; agency policies about
prevention of HIV, viral hepatitis and other STDs; treatment,
healthcare delivery, and research and training; strategic issues
influencing the ability of CDC and HRSA to fulfill their missions of
providing prevention and treatment services; programmatic efforts to
prevent and treat HIV, viral hepatitis, and other STDs; and support to
the agencies in their developoment of responses to emerging health
needs related to HIV, viral hepatitis, and other STDs.
During the March 5, 2020, meeting, CHAC will discuss issues related
to a CDC pilot on recency assay-based incidence estimation and the
President's initiative on ``Ending the HIV Epidemic: A Plan for
America.'' Agenda items are subject to change as priorities dictate.
Due to the nature and time limitations of the meeting, members of
the public will not have an opportunity to provide oral comments,
although written comments may be submitted prior to the meeting, or up
to 5 business days after the meeting, to Theresa Jumento at the contact
information listed above. Individuals who plan to attend and need
special assistance or another reasonable accommodation should notify
Theresa Jumento at the address and phone number listed above at least
10 business days prior to the meeting.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2020-01809 Filed 1-30-20; 8:45 am]
BILLING CODE 4165-15-P
